Jonathan Hunt

Insider Reports History

Entity
Individual
Location
2401 Elliott Avenue, Suite 320, Seattle, WA
Signature
/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Hunt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Perspective Therapeutics, Inc. Chief Financial Officer Common Stock 48.8K $189K $3.88 Nov 25, 2024 Direct
Perspective Therapeutics, Inc. Chief Financial Officer Stock option (right to buy) 100K Jun 20, 2024 Direct

Insider Reports Filed by Jonathan Hunt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CATX Perspective Therapeutics, Inc. Nov 25, 2024 4 $49K 4 Nov 27, 2024 Chief Financial Officer
CATX Perspective Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Chief Financial Officer
CATX Perspective Therapeutics, Inc. Jun 17, 2024 1 $17.7K 4 Jun 18, 2024 Chief Financial Officer
CATX Perspective Therapeutics, Inc. May 31, 2024 2 $35K 4 Jun 3, 2024 Chief Financial Officer
CATX Perspective Therapeutics, Inc. Dec 18, 2023 1 $32.3K 4 Dec 19, 2023 Chief Financial Officer
CATX Perspective Therapeutics, Inc. Dec 12, 2023 1 $0 4 Dec 14, 2023 Chief Financial Officer
CATX Isoray, Inc. Dec 1, 2022 2 $32.5K 4 Dec 5, 2022 Chief Financial Officer
CATX Isoray, Inc. Jul 21, 2022 1 $0 4 Jul 28, 2022 Chief Financial Officer
CATX Isoray, Inc. Jun 7, 2022 2 $11.2K 4 Jun 9, 2022 Chief Financial Officer
CATX Isoray, Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Chief Financial Officer